MCID: GNG004
MIFTS: 50

Ganglioglioma malady

Categories: Rare diseases, Neuronal diseases, Cancer diseases

Aliases & Classifications for Ganglioglioma

About this section
Sources:
11Disease Ontology, 13DISEASES, 39MeSH, 45NCIt, 48NIH Rare Diseases, 50Novoseek, 54Orphanet, 62SNOMED-CT, 68UMLS, 69UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Ganglioglioma:

Name: Ganglioglioma 11 48 54 50 39 13 68
Childhood Ganglioglioma 11 68
Adult Ganglioglioma 11 68
 
Mixed Cell Tumors Containing Both Neural Ganglionic Cells and Neural Glial Cell Components 48
Cns Ganglioglioma 11

Classifications:



External Ids:

Disease Ontology11 DOID:5078
MeSH39 D018303
Orphanet54 ORPHA251949
UMLS via Orphanet69 C0206716

Summaries for Ganglioglioma

About this section
NIH Rare Diseases:48 A ganglioglioma is a rare type of brain tumor, accounting for approximately 1% of all brain tumors.  gangliogliomas occur when a single cell in the brain starts to divide into more cells, forming a tumor.  this can occur when the cell randomly acquires changes (mutations) in genes that regulate how a cell divides.  most gangliogliomas grow slowly and are considered benign.  however, up to 10% of gangliogliomas may grow more rapidly and become malignant, meaning the tumor affects the surrounding brain tissue.    the main treatment for ganglioglioma is removal of the entire tumor during surgery.  if the entire tumor is not removed, it has the potential to recur and may require additional surgery or treatments, such as radiation therapy or chemotherapy.  unfortunately, because gangliogliomas are quite rare, there is limited information to show that radiation therapy or chemotherapy are effective treatments for this condition. last updated: 7/11/2011

MalaCards based summary: Ganglioglioma, also known as childhood ganglioglioma, is related to pleomorphic xanthoastrocytoma and pilocytic astrocytoma, and has symptoms including seizures, seizures and seizures. An important gene associated with Ganglioglioma is SYP (Synaptophysin), and among its related pathways are Thyroid cancer and p53 Pathway (RnD). Affiliated tissues include brain, temporal lobe and spinal cord, and related mouse phenotypes are Increased proliferation and neoplasm.

Disease Ontology:11 A cell type benign neoplasm that has material basis in glial-type cells.

Wikipedia:71 Ganglioglioma is a rare, slow-growing primary central nervous system (CNS) tumor which most frequently... more...

Related Diseases for Ganglioglioma

About this section

Diseases related to Ganglioglioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 229)
idRelated DiseaseScoreTop Affiliating Genes
1pleomorphic xanthoastrocytoma30.0GFAP, SYP, TSC1, TSC2
2pilocytic astrocytoma29.7GFAP, SYP, TSC1, TSC2
3basal cell nevus syndrome28.5GFAP, MAP2, NES, SMARCB1, SYP, TP53
4anaplastic ganglioglioma12.3
5desmoplastic infantile ganglioglioma12.0
6desmoplastic infantile astrocytoma/ganglioglioma11.9
7nasal ganglioglioma11.9
8gangliocytoma11.2
9diabetes hypogonadism deafness mental retardation10.3GFAP, SYP
10papillary tumor of the pineal region10.3GFAP, SYP
11hypothalamic neoplasm10.3GFAP, NES
12intrahepatic bile duct adenoma10.3GFAP, SYP
13angiofollicular lymph hyperplasia10.3GFAP, NES
14pilocytic astrocytoma of cerebellum10.3GFAP, SYP
15epidermal appendage tumor10.3GFAP, SYP
16childhood kidney cell carcinoma10.3GFAP, NES
17peroneal nerve paralysis10.3CHGA, SYP
18thymus small cell carcinoma10.3CHGA, SYP
19cerebral folate receptor alpha deficiency10.3GFAP, SYP
20non specific chronic endometritis10.3CHGA, SYP
21extrahepatic biliary papillomatosis10.3CHGA, SYP
22prolactin producing pituitary tumor10.3CHGA, SYP
23epithelioid malignant peripheral nerve sheath tumor10.3CHGA, SYP
24cartilage cancer10.3CHGA, SYP
25villous adenocarcinoma10.3CHGA, SYP
26renal pelvis adenocarcinoma10.2CHGA, SYP
27spasmodic dysphonia10.2CHGA, SYP
28endometrial stromal sarcoma10.2CHGA, GFAP
29barre-lieou syndrome10.2CHGA, SYP
30myelinoclastic diffuse sclerosis10.2GFAP, S100B
31gastric duplication cysts10.2CHGA, SYP
32diffuse cutaneous mastocytosis10.2CHGA, SYP
33mediastinal granular cell myoblastoma10.2GFAP, SYP
34bronchial mucus gland adenoma10.2GFAP, S100B
35spleen angiosarcoma10.2GFAP, S100B
36ovarian cystadenoma10.2GFAP, S100B
37central neurocytoma10.2GFAP, SYP
38melorheostosis with osteopoikilosis10.2TSC1, TSC2
39liver fibrosarcoma10.2GFAP, TP53
40well-differentiated thymic neuroendocrine carcinoma10.2BRAF, TP53
41main bronchus cancer10.2CHGA, SYP
42nephrogenic adenoma of urinary bladder10.2GFAP, NES, SYP
43cervical adenoid cystic carcinoma10.2GFAP, TP53
44gliofibroma10.2CHGA, SYP
45male reproductive system disease10.2GFAP, NES, SYP
46pineal gland astrocytoma10.2BRAF, TP53
47glomeruloid hemangioma10.2BRAF, GFAP, SYP
48corneal intraepithelial neoplasm10.2S100B, SYP
49spondylarthropathy10.2BRAF, TP53
50bronchitis10.2GFAP, TP53

Graphical network of the top 20 diseases related to Ganglioglioma:



Diseases related to ganglioglioma

Symptoms & Phenotypes for Ganglioglioma

About this section

UMLS symptoms related to Ganglioglioma:


seizures

GenomeRNAi Phenotypes related to Ganglioglioma according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00094-A10.0SMARCB1, TP53

MGI Mouse Phenotypes related to Ganglioglioma according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020068.6BRAF, SMARCB1, TP53, TSC1, TSC2
2MP:00053858.0BRAF, CHGA, GFAP, SMARCB1, TP53, TSC1
3MP:00036317.6BRAF, GFAP, MAP2, SMARCB1, SYP, TP53
4MP:00053787.6BRAF, CHGA, GFAP, MAP2, SMARCB1, TP53
5MP:00053867.3BRAF, GFAP, MAP2, S100B, SMARCB1, SYP
6MP:00053897.1BRAF, CHGA, MAP2, SMARCB1, TP53, TSC1

Drugs & Therapeutics for Ganglioglioma

About this section

Drugs for Ganglioglioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 16)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
DabrafenibapprovedPhase 28444462760, 44516822
Synonyms:
BRAF inhibitor GSK2118436
Dabrafenib
 
GSK2118436
GSK2118436a
Tafinlar
dabrafenib
2Protein Kinase InhibitorsPhase 23689
3
Bevacizumabapproved, investigationalPhase 12020216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
4
Irinotecanapproved, investigationalPhase 1112397682-44-5, 100286-90-660838
Synonyms:
(+)-Irinotecan
(4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4'-BIPIPERIDINE-1'-CARBOXYLATE
(4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-4,12-dihydro-1H-pyrano[3,4-f]quinolino[2,3-a]indolizin-9-yl 4-piperidylpiperidinecarboxylate
1u65
97682-44-5
AC-7469
AC1L1U0Z
AC1Q6PGI
BRD-K08547377-003-02-4
BSPBio_002346
Bio-0054
Biotecan
Biotecan (TN)
C16641
C33H38N4O6
CHEBI:105985
CHEMBL481
CID60838
CP0
Campothecin-11
Campto
Camptosar
 
Camptosar, Campto, CPT-11, Irinotecan
Camptothecin-11
D08086
DB00762
FT-0083650
HSDB 7607
IRINOTECAN HYDROCHLORIDE Trihydrate
IRINOTECAN, CPT-11
Irinotecan (INN)
Irinotecan Hcl
Irinotecan Hydrochloride
Irinotecan Hydrochloride Trihydrate
Irinotecan [INN:BAN]
Irinotecan hydrochloride
Irinotecanum
Irinotecanum [INN-Latin]
LS-44589
NCI60_005051
NSC728073
S1198_Selleck
TL8006026
UNII-7673326042
irinotecan
5
Cyclophosphamideapproved, investigationalPhase 1293550-18-0, 6055-19-22907
Synonyms:
(+-)-Cyclophosphamide
(-)-Cyclophosphamide
(RS)-Cyclophosphamide
1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
4-Hydroxy-cyclophosphan-mamophosphatide
50-18-0
60007-95-6
6055-19-2 (monohydrate)
75526-90-8
AC1L1EQQ
AI3-26198
ASTA
ASTA B518
Anhydrous cyclophosphamide
Asta B 518
B 518
B-518
BRN 0011744
BSPBio_002099
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
C 0768
C07888
C7H15Cl2N2O2P
CB 4564
CB-4564
CCRIS 188
CHEBI:4027
CHEMBL32520
CHEMBL88
CID2907
CP
CPA
CTX
CY
Ciclofosfamida
Ciclofosfamida [INN-Spanish]
Ciclofosfamide
Ciclophosphamide
Ciclophosphamide [INN]
Clafen
Claphene
Cycloblastin
Cyclophosphamid
Cyclophosphamide
Cyclophosphamide (INN)
Cyclophosphamide (TN)
Cyclophosphamide (anhydrous form)
Cyclophosphamide (anhydrous)
Cyclophosphamide Monohydrate
Cyclophosphamide Sterile
Cyclophosphamide anhydrous
Cyclophosphamide, (+-)-Isomer
Cyclophosphamides
Cyclophosphamidum
Cyclophosphamidum [INN-Latin]
Cyclophosphan
Cyclophosphane
Cyclophosphanum
Cyclophosphoramide
Cyclostin
Cyklofosfamid
Cyklofosfamid [Czech]
Cytophosphan
Cytophosphane
Cytoxan
Cytoxan (TN)
Cytoxan Lyoph
D,L-Cyclophosphamide
D07760
 
DB00531
DivK1c_000246
EINECS 200-015-4
EU-0100238
Endoxan
Endoxan R
Endoxan-Asta
Endoxana
Endoxanal
Endoxane
Enduxan
Genoxal
HMS2090A12
HSDB 3047
Hexadrin
IDI1_000246
KBio1_000246
KBio2_001338
KBio2_003906
KBio2_006474
KBio3_001319
KBioGR_000888
KBioSS_001338
LS-1302
LS-99787
Ledoxina
Lopac-C-0768
Lopac0_000238
Lyophilized Cytoxan
Mitoxan
MolPort-001-783-420
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
NCGC00015209-01
NCGC00015209-03
NCGC00015209-06
NCGC00091741-02
NCGC00091741-03
NCI-C04900
NCI60_002097
NINDS_000246
NSC 26271
NSC-26271
NSC26271
NSC273033
NSC273034
Neosar
Occupation, cyclophosphamide exposure
Procytox
RCRA waste no. U058
Rcra Waste Number U058
Rcra waste number U058
Revimmune
S1217_Selleck
SK 20501
SPBio_001071
STK177249
STOCK2S-91217
Semdoxan
Sendoxan
Senduxan
Spectrum2_001146
Spectrum3_000370
Spectrum4_000304
Spectrum5_000795
Spectrum_000858
UNII-6UXW23996M
WLN: T6MPOTJ BO BN2G2G
Zyklophosphamid
Zyklophosphamid [German]
bis(2-Chloroethyl)phosphami de cyclic propanolamide
bis(2-Chloroethyl)phosphamide cyclic propanolamide ester
cyclophosphamide
6
CamptothecinexperimentalPhase 17147689-03-4
Synonyms:
(+)-camptothecin
(+)-camptothecine
(s)-(+)-camptothecin
 
(s)-camptothecin
20(S)-Camptothecin
21,22-Secocamptothecin-21-oic acid lactone
Camptothecine
D-camptothecin
7Antineoplastic Agents, PhytogenicPhase 15602
8topoisomerase I inhibitorsPhase 11370
9Topoisomerase InhibitorsPhase 15069
10Angiogenesis InhibitorsPhase 14257
11Angiogenesis Modulating AgentsPhase 14185
12Immunosuppressive AgentsPhase 113086
13Antirheumatic AgentsPhase 110956
14Antineoplastic Agents, AlkylatingPhase 14603
15Alkylating AgentsPhase 14827
16AnestheticsPhase 19596

Interventional clinical trials:

idNameStatusNCT IDPhase
1Antineoplaston Therapy in Treating Children With Brain TumorsCompletedNCT00003458Phase 2
2Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain IrradiationRecruitingNCT01288235Phase 2
3Phase II Pediatric Study With Dabrafenib in HGG PatientsNot yet recruitingNCT02684058Phase 2
4Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS TumorsCompletedNCT01999270Phase 1
5A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2Not yet recruitingNCT03152318Phase 1
6Astrocytoma / Desmoplastic Gamliogliomes (DIA / DIG) - Study of the French Cohort of the Last 20 Years : Clinical, Anatomopathological, Molecular and Radiological CharactersicsRecruitingNCT03115164

Search NIH Clinical Center for Ganglioglioma


Cochrane evidence based reviews: ganglioglioma

Genetic Tests for Ganglioglioma

About this section

Anatomical Context for Ganglioglioma

About this section

MalaCards organs/tissues related to Ganglioglioma:

36
Brain, Temporal lobe, Spinal cord, Cerebellum, Pineal, Cortex, Thalamus

Publications for Ganglioglioma

About this section

Articles related to Ganglioglioma:

(show top 50)    (show all 444)
idTitleAuthorsYear
1
Longitudinal mutational analysis of a cerebellar pilocytic astrocytoma recurring as a ganglioglioma. (27718322)
2017
2
Desmoplastic infantile astrocytoma and ganglioglioma: case report and review of the literature. (27668845)
2017
3
Ganglioglioma of the posterior third ventricle region: An unusual pathology in an uncommon location. (26954825)
2016
4
Progression of Atypical Extraventricular Neurocytoma to Anaplastic Ganglioglioma. (27597523)
2016
5
Pediatric intracranial primary anaplastic ganglioglioma. (27921213)
2016
6
Infratentorial ganglioglioma mimicking pilocytic astrocytoma. (27936528)
2016
7
Desmoplastic infantile astrocytoma/ganglioglioma with rare BRAF V600D mutation. (27860162)
2016
8
Diffusion, Perfusion, and Histopathologic Characteristics of Desmoplastic Infantile Ganglioglioma. (27761184)
2016
9
Bilateral internal auditory canal gangliogliomas mimicking neurofibromatosis Type II. (27127704)
2016
10
Journal Club: Pediatric Low-Grade Ganglioglioma: Epidemiology, Treatments, and Outcome Analysis on 348 Children From the Surveillance, Epidemiology, and End Results Database. (27428631)
2016
11
Application of diffusion-weighted imaging and dynamic susceptibility contrast perfusion-weighted imaging for ganglioglioma in adults: Comparison study with oligodendroglioma. (27502573)
2016
12
Recurrent ganglioglioma in adults treated with BRAF inhibitors. (26680369)
2016
13
Response to Journal Club: Pediatric Low-Grade Ganglioglioma: Epidemiology, Treatments, and Outcome Analysis of 348 Children From the Surveillance, Epidemiology, and End Results Database. (27428632)
2016
14
Combined pleomorphic xanthoastrocytoma-ganglioglioma with BRAF V600E mutation: case report. (27015517)
2016
15
Newly diagnosed ganglioglioma in an adult patient with multiple sclerosis. (27653865)
2016
16
Clinical Neuropathology image 5-2016: nNeurofibrillary tangle-rich ganglioglioma. (27546017)
2016
17
Genetic Characterization of a Multifocal Ganglioglioma Originating Within the Spinal Cord. (27671879)
2016
18
Abundance of LRP12 C-rs9694676 allelic promoter variant in epilepsy-associated gangliogliomas. (27142828)
2016
19
Long-term drug-resistant temporal lobe epilepsy associated with a mixed ganglioglioma and dysembryoplastic neuroepithelial tumor in an elderly patient. (27127715)
2016
20
Ganglioglioma arising from olfactory sheath: A rare site of an uncommon tumor. (26874814)
2016
21
Growth hormone secreting pituitary adenoma with admixed gangliocytoma and ganglioglioma. (27068013)
2016
22
Co-occurrence of Histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma. (27984673)
2016
23
Ganglioglioma of conus medullaris in a patient of neurofibromatosis type 1: A novel association? (27695570)
2016
24
Unusual ganglioglioma with extensive calcification and ossification. (27510688)
2016
25
Personalized Treatment for a Patient With a BRAF V600E Mutation Using Dabrafenib and a Tumor Treatment Fields Device in a High-Grade Glioma Arising From Ganglioglioma. (27799506)
2016
26
Ganglioglioma: Single-institutional experience of 24 cases with review of literature. (27695546)
2016
27
Desmoplastic infantile ganglioglioma with focal cortical dysplasia: A rare double pathology in an infant with history of seizures. (26991995)
2016
28
Supratentorial tumors typical of the infantile age: desmoplastic infantile ganglioglioma (DIG) and astrocytoma (DIA). A review. (27659826)
2016
29
Concurrent Intraventricular and Sacral Spinal Drop Metastasis of Ganglioglioma in an Adult Patient: A Case Report and Review of Literature. (27158568)
2016
30
Successful Retreatment of a Child with a Refractory Brainstem Ganglioglioma with Vemurafenib. (26579623)
2016
31
Serial imaging and management of ganglioglioma with unusual presentation and meningeal spread. (27853879)
2016
32
Clinical, Imaging, Histopathological and Molecular Characterization of Anaplastic Ganglioglioma. (27539475)
2016
33
K27M mutation in H3F3A in ganglioglioma grade I with spontaneous malignant transformation extends the histopathological spectrum of the histone H3 oncogenic pathway. (27219822)
2016
34
Coexistent ganglioglioma, focal cortical dysplasia, and hippocampal sclerosis (triple pathology) in chronic epilepsy. (26235882)
2015
35
Anaplastic ganglioglioma: a report of three cases and review of the literature. (25862009)
2015
36
Dysplastic Cerebellar Epilepsy: Complete Seizure Control Following Resection of a Ganglioglioma. (26208704)
2015
37
Non-infantile variant of desmoplastic ganglioglioma: Conventional and advanced MR imaging characteristics. (26246092)
2015
38
Desmoplastic infantile ganglioglioma with associated giant aneurysma89case report. (25922053)
2015
39
Pediatric low-grade ganglioglioma: epidemiology, treatments, and outcome analysis on 348 children from the surveillance, epidemiology, and end results database. (25603107)
2015
40
Pediatric infratentorial ganglioglioma. (26351224)
2015
41
Bilateral Optic Pathway Ganglioglioma: The Fifth Case in the Literature. (26488468)
2015
42
BRAF V600E mutation in neocortical posterior temporal epileptogenic gangliogliomas. (25937573)
2015
43
Pigmented ganglioglioma in a patient with chronic epilepsy and cortical dysplasia. (26432496)
2015
44
An Unusual Case of Constitutional Mismatch Repair Deficiency Syndrome With Anaplastic Ganglioglioma, Colonic Adenocarcinoma, Osteosarcoma, Acute Myeloid Leukemia, and Signs of Neurofibromatosis Type 1: Case Report. (25850602)
2015
45
Differential expression and clinical significance of three inflammation-related microRNAs in gangliogliomas. (25986346)
2015
46
Atypical pediatric ganglioglioma is common and associated with a less favorable clinical course. (26431248)
2015
47
Ganglioglioma of the Spinal Cord. (26605127)
2015
48
Suggestive value of predilection site and imaging features of pediatric brainstem ganglioglioma including a case report. (25665772)
2015
49
Recurrent papillary glioneuronal tumor presenting as a ganglioglioma with the BRAF V600E mutation. (26073619)
2015
50
Greater extent of resection improves ganglioglioma recurrence-free survival in children: a volumetric analysis. (24625425)
2014

Variations for Ganglioglioma

About this section

Cosmic variations for Ganglioglioma:

8
id Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Mutation CDS Mutation AA Conf
1COSM476BRAFcentral nervous system,brain,other,gangliogliomac.1799T>Ap.V600E9
2COSM28746IDH1central nervous system,brain,other,gangliogliomac.395G>Ap.R132H9
3COSM99759IDH2central nervous system,temporal lobe,other,gangliogliomac.492G>Ap.W164*9
4COSM28748IDH1central nervous system,brain,other,neoplasmc.394C>Ap.R132S3
5COSM28747IDH1central nervous system,brain,other,neoplasmc.394C>Tp.R132C3
6COSM28749IDH1central nervous system,brain,other,neoplasmc.394C>Gp.R132G3
7COSM28750IDH1central nervous system,brain,other,neoplasmc.395G>Tp.R132L3

Expression for genes affiliated with Ganglioglioma

About this section
Search GEO for disease gene expression data for Ganglioglioma.

Pathways for genes affiliated with Ganglioglioma

About this section

GO Terms for genes affiliated with Ganglioglioma

About this section

Cellular components related to Ganglioglioma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1TSC1-TSC2 complexGO:00335969.6TSC1, TSC2

Biological processes related to Ganglioglioma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1negative regulation of insulin receptor signaling pathwayGO:004662710.1TSC1, TSC2
2negative regulation of TOR signalingGO:003200710.1TSC1, TSC2
3positive regulation of macroautophagyGO:001623910.0TSC1, TSC2
4cell cycle arrestGO:00070509.8TP53, TSC1, TSC2
5regulation of neuronal synaptic plasticityGO:00481689.8S100B, SYP
6negative regulation of cell proliferationGO:00082858.9SMARCB1, TP53, TSC1, TSC2

Molecular functions related to Ganglioglioma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1small GTPase bindingGO:00312679.6BRAF, TSC2
2identical protein bindingGO:00428028.9BRAF, GFAP, S100B, SYP, TP53

Sources for Ganglioglioma

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet